Literature DB >> 9522996

In vitro reactivity of mast cells in urticaria pigmentosa skin.

E Brzezińska-Błaszczyk1, A Zalewska.   

Abstract

The aim of our study was to evaluate the sensitivity of skin mast cells from urticaria pigmentosa (UP) patients to substance P (SP), tumor necrosis factor alpha (TNF-alpha) and anti-IgE, and to compare the sensitivity of these cells with that of skin mast cells from healthy human donors. Mast cells for in vitro functional studies were obtained using an enzymatic dispersion technique from skin biopsies (from 11 patients with UP and 11 healthy donors), and the reactivity of these cells was estimated on the basis of histamine release. Our observations indicated that UP skin mast cells and healthy skin mast cells had similar sensitivities to challenge with TNF-alpha at a concentration 10(-7) M (16.4% vs 15.2%) and with anti-IgE at a dilution 1:100 (41.0% vs 37.0%). However, UP mast cells showed considerably higher sensitivity to challenge with SP at a concentration 10(-4) M than healthy skin mast cells (20.0% vs 6.8%), and the difference was statistically significant (P < 0.001). UP skin mast cells also demonstrated significantly higher spontaneous histamine release than healthy skin mast cells (32.1% vs 12.4%, P < 0.001). Our findings indicating UP skin mast cell sensitivity to SP might suggest that mechanisms involving neurogenic inflammation could contribute to the course of this disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9522996     DOI: 10.1007/s004030050270

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  3 in total

1.  Expression of MRGPRX2 in skin mast cells of patients with maculopapular cutaneous mastocytosis.

Authors:  Vishwa Deepak; Hirsh D Komarow; Abdulaziz A Alblaihess; Melody C Carter; Dean D Metcalfe; Hydar Ali
Journal:  J Allergy Clin Immunol Pract       Date:  2021-06-25

2.  Prostaglandin D2-supplemented "functional eicosanoid testing and typing" assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study.

Authors:  Dirk Schäfer; Peter Dreßen; Stefan Brettner; Norbert-Folke Rath; Gerhard J Molderings; Katrin Jensen; Christina Ziemann
Journal:  J Transl Med       Date:  2014-08-12       Impact factor: 5.531

3.  Inhibition of Orai Channel Function Regulates Mas-Related G Protein-Coupled Receptor-Mediated Responses in Mast Cells.

Authors:  Shaswati Chaki; Ibrahim Alkanfari; Saptarshi Roy; Aetas Amponnawarat; Yvonne Hui; Carole A Oskeritzian; Hydar Ali
Journal:  Front Immunol       Date:  2022-01-20       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.